BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35128805)

  • 21. Tenascin-X, collagen, and Ehlers-Danlos syndrome: tenascin-X gene defects can protect against adverse cardiovascular events.
    Petersen JW; Douglas JY
    Med Hypotheses; 2013 Sep; 81(3):443-7. PubMed ID: 23830591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A TNXB splice donor site variant as a cause of hypermobility type Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia.
    Lao Q; Mallappa A; Rueda Faucz F; Joyal E; Veeraraghavan P; Chen W; Merke DP
    Mol Genet Genomic Med; 2021 Feb; 9(2):e1556. PubMed ID: 33332743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital adrenal hyperplasia with a
    Ivo CR; Fitas AL; Madureira I; Diamantino C; Gomes S; Gonçalves J; Lopes L
    J Pediatr Endocrinol Metab; 2023 Jan; 36(1):81-85. PubMed ID: 36259452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenascin-X deficiency and Ehlers-Danlos syndrome: a case report and review of the literature.
    O'Connell M; Burrows NP; van Vlijmen-Willems MJ; Clark SM; Schalkwijk J
    Br J Dermatol; 2010 Dec; 163(6):1340-5. PubMed ID: 20649799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compound heterozygosity for TNXB genetic variants in a mixed-breed dog with Ehlers-Danlos syndrome.
    Bauer A; de Lucia M; Leuthard F; Jagannathan V; Leeb T
    Anim Genet; 2019 Oct; 50(5):546-549. PubMed ID: 31365140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypersensitivity of myelinated A-fibers via toll-like receptor 5 promotes mechanical allodynia in tenascin-X-deficient mice associated with Ehlers-Danlos syndrome.
    Kamada H; Emura K; Yamamoto R; Kawahara K; Uto S; Minami T; Ito S; Matsumoto KI; Okuda-Ashitaka E
    Sci Rep; 2023 Oct; 13(1):18490. PubMed ID: 37898719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel defects in collagen XII and VI expand the mixed myopathy/Ehlers-Danlos syndrome spectrum and lead to variant-specific alterations in the extracellular matrix.
    Delbaere S; Dhooge T; Syx D; Petit F; Goemans N; Destrée A; Vanakker O; De Rycke R; Symoens S; Malfait F
    Genet Med; 2020 Jan; 22(1):112-123. PubMed ID: 31273343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome.
    Bristow J; Carey W; Egging D; Schalkwijk J
    Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):24-30. PubMed ID: 16278880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenascin-X as a causal gene for classical-like Ehlers-Danlos syndrome.
    Okuda-Ashitaka E; Matsumoto KI
    Front Genet; 2023; 14():1107787. PubMed ID: 37007968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CAH-X Syndrome: Genetic and Clinical Profile.
    Concolino P; Falhammar H
    Mol Diagn Ther; 2022 May; 26(3):293-300. PubMed ID: 35476220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The Ehlers-Danlos syndrome: the extracellular matrix scaffold in question].
    Fichard A; Chanut-Delalande H; Ruggiero F
    Med Sci (Paris); 2003 Apr; 19(4):443-52. PubMed ID: 12836217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module.
    Lee HH
    Mol Genet Metab; 2005 Jan; 84(1):4-8. PubMed ID: 15639189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Well-defined clinical presentation of Ehlers-Danlos syndrome in patients with tenascin-X deficiency: a report of four cases.
    Hendriks AGM; Voermans NC; Schalkwijk J; Hamel BC; van Rossum MM
    Clin Dysmorphol; 2012 Jan; 21(1):15-18. PubMed ID: 21959861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome.
    Miller WL; Merke DP
    Horm Res Paediatr; 2018; 89(5):352-361. PubMed ID: 29734195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel gross deletion mutation c.-105_4042+498del in the TNXB gene in a Japanese woman with classical-like Ehlers-Danlos syndrome: A case of uneventful pregnancy and delivery.
    Watanabe S; Ito Y; Samura O; Nakano H; Sawamura D; Asahina A; Itoh M
    J Dermatol; 2021 May; 48(5):e227-e228. PubMed ID: 33721335
    [No Abstract]   [Full Text] [Related]  

  • 36. Recognizing the tenascin-X deficient type of Ehlers-Danlos syndrome: a cross-sectional study in 17 patients.
    Demirdas S; Dulfer E; Robert L; Kempers M; van Beek D; Micha D; van Engelen BG; Hamel B; Schalkwijk J; Loeys B; Maugeri A; Voermans NC
    Clin Genet; 2017 Mar; 91(3):411-425. PubMed ID: 27582382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNX deficiency results in bone loss due to an increase in multinucleated osteoclasts.
    Kajitani N; Yamada T; Kawakami K; Matsumoto KI
    Biochem Biophys Res Commun; 2019 May; 512(4):659-664. PubMed ID: 30922562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation in
    Kaufman CS; Butler MG
    World J Med Genet; 2016 May; 6(2):17-21. PubMed ID: 28344932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel role for the extracellular matrix glycoprotein-Tenascin-X in gastric function.
    Aktar R; Peiris M; Fikree A; Eaton S; Kritas S; Kentish SJ; Araujo EJA; Bacarin C; Page AJ; Voermans NC; Aziz Q; Blackshaw LA
    J Physiol; 2019 Mar; 597(6):1503-1515. PubMed ID: 30605228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel COL3A1 variant associated with vascular Ehlers-Danlos syndrome in a patient presents as recurrent pneumothorax with cavities.
    Guo T; Liu Y; Lvqiu S; Lei C; He WL; Jiang Y; Yang D; Wang R; Yang B; Lu C; Xu Y; Ding S; Wang L; Luo H; Peng H
    QJM; 2023 Sep; 116(8):691-693. PubMed ID: 37074961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.